Efficacy and Safety Profile of Combining Sorafenib with Chemotherapy in Patients with HER2-Negative Advanced Breast Cancer: A Meta-analysis

Jie Chen,Chun‐Xiang Tian,Miao Yu,Qing Lv,Nan-Sheng Cheng,Zu Wang,Xi Wu

Efficacy and Safety Profile of Combining Sorafenib with Chemotherapy in Patients with HER2-Negative Advanced Breast Cancer: A Meta-analysis

2014

Jie Chen
Chun‐Xiang Tian
Miao Yu
Qing Lv
Nan-Sheng Cheng
Zu Wang
Xi Wu

Purpose The aim of the study was to evaluate the efficacy and safety of combining sorafenib with chemotherapy in patients with human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer.

Keywords:

Oncology
HER2 negative
Breast cancer
Meta-analysis
Pathology
Sorafenib
Chemotherapy
Medicine
Internal medicine
Human Epidermal Growth Factor Receptor 2
Text mining
Bioinformatics
Randomized controlled trial
Hazard ratio
Subgroup analysis
Cancer
General surgery
Adverse effect

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations